Fernando de Alvaro
Overview
Explore the profile of Fernando de Alvaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Banegas J, Jovell A, Abarca B, Aguilar Diosdado M, Aguilera L, Aranda P, et al.
Med Clin (Barc)
. 2009 Feb;
132(6):222-9.
PMID: 19237007
No abstract available.
12.
Lobos J, Royo-Bordonada M, Brotons C, Alvarez-Sala L, Armario P, Maiques A, et al.
Rev Esp Salud Publica
. 2009 Jan;
82(6):581-616.
PMID: 19180272
We present the Spanish adaptation from the CEIPC of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The...
13.
Macdougall I, Walker R, Provenzano R, de Alvaro F, Locay H, Nader P, et al.
Clin J Am Soc Nephrol
. 2008 Feb;
3(2):337-47.
PMID: 18287255
Background And Objectives: This study examined the efficacy of C.E.R.A., a continuous erythropoietin receptor activator, for correcting anemia in patients who had chronic kidney disease (CKD) and were not on...
14.
Costero O, de Alvaro F, Bernardino I, Selgas R
Med Clin (Barc)
. 2007 Oct;
129(9):358-9.
PMID: 17910857
No abstract available.
15.
Ritz E, Laville M, Bilous R, ODonoghue D, Scherhag A, Burger U, et al.
Am J Kidney Dis
. 2007 Jan;
49(2):194-207.
PMID: 17261422
Background: Patients with diabetes and anemia are at high risk of cardiovascular disease. The Anemia CORrection in Diabetes (ACORD) Study aimed to investigate the effect of anemia correction on cardiac...
16.
Alcazar R, Gonzalez Albarran O, Honorato J, Robles N, Acha J, de Alvaro F, et al.
Nefrologia
. 2006 Nov;
26(5):538-58.
PMID: 17117897
No abstract available.
17.
Cea-Calvo L, Conthe P, Gomez-Fernandez P, de Alvaro F, Fernandez-Perez C
Cardiovasc Diabetol
. 2006 Nov;
5:23.
PMID: 17083718
Background: Target organ damage (mainly cardiac and renal damage) is easy to evaluate in outpatient clinics and offers valuable information about patient's cardiovascular risk. The purpose of this study was...
18.
de Alvaro F, Hernandez-Presa M
J Cardiovasc Pharmacol
. 2006 Feb;
47(2):271-6.
PMID: 16495766
Objective: To evaluate extended-release doxazosin gastrointestinal therapeutic system (GITS) as add-on therapy in patients with treated, but uncontrolled hypertension. Methods: A 16-week, open, noncomparative, multicenter, prospective study of patients with...
19.
Martinez-Castelao A, de Alvaro F, Gorriz J
Kidney Int Suppl
. 2005 Dec;
(99):S20-4.
PMID: 16336572
Background: The incidence of diabetes mellitus (DM) has increased persistently in recent years and is becoming an epidemic. Some have estimated that 4.4% of the world's population will be diabetic...
20.
Pohl M, Blumenthal S, Cordonnier D, de Alvaro F, Deferrari G, Eisner G, et al.
J Am Soc Nephrol
. 2005 Aug;
16(10):3027-37.
PMID: 16120823
Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy. However, the component of arterial pressure and level of BP control for optimal renal outcomes...